
CDMO Samsung Biologics telegraphs spinoff of biosim unit
In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its biosimilars development unit. Starting later this year, Samsung Bio will devote itself fully to contract manufacturing under a plan to …